Evidence map›Paper›PMID 34632727›Full record

ReviewAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

Emerging Roles of Energy Metabolism in Ferroptosis Regulation of Tumor Cells.

Xuemei Yao, Wei Li, De Fang, Chuyu Xiao, Xiao Wu, Menghuan Li, Zhong Luo

Open access · goldAbstract readReview
In one paragraph

Review in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 140 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
140citing papers in PubMed, 2 pooled it
26.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

140 citing papers in PubMed, 2 syntheses or guidelines pooled it, 265 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. The emerging roles of disulfidptosis in cancer.Apoptosis : an international journal on programmed cell death · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. mRedox biology · 2026
    Review
  17. Article
  18. Article
  19. Article
  20. Article

80 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Xuemei YaoSchool of Life Science, Chongqing University, Chongqing, 400044, China.
Wei LiBreast Cancer Center, Chongqing Key Laboratory of Translational Research for Cancer Metastasis and Individualized Treatment, Chongqing University Cancer Hospital, Chongqing, 400044, P. R. China.
De FangSchool of Life Science, Chongqing University, Chongqing, 400044, China.
Chuyu XiaoSchool of Life Science, Chongqing University, Chongqing, 400044, China.
Xiao WuSchool of Life Science, Chongqing University, Chongqing, 400044, China.
Menghuan LiSchool of Life Science, Chongqing University, Chongqing, 400044, China.
Zhong LuoSchool of Life Science, Chongqing University, Chongqing, 400044, China.ORCID 0000-0002-9019-3314
Chongqing University · CN

Funding

Central University's basic scientific research business fee medical integration project 2019CDYGYB004Central University's basic scientific research business fee medical integration project 2020CDJYGZL009Chongqing Graduate Scientific Research and Innovation Program cYB20047Chongqing Graduate Scientific Research and Innovation Program cYS20043Chongqing Municipal Education Commission Science and Technology Research Project KJQN201800109Chongqing Outstanding Young Talent Supporting Program CQYC201905072Chongqing Science and Technology Commission cstc2020jcyj-msxmX0834Fundamental Research Funds for the Central Universities 2020CDJQY-A075Fundamental Research Funds for the Central Universities 2020CDJYGZL009Key Technologies Research and Development Program 2017YFB0702603National Key R&D Program of China 2017YFB0702603National Natural Science Foundation of China 11832008National Natural Science Foundation of China 51603024National Natural Science Foundation of China 51773023National Natural Science Foundation of China 92059107Natural Science Foundation of Chongqing Municipal Government cstc2018jcyjAX0368Natural Science Foundation of Chongqing Municipal Government cstc2020jcyj-msxmX0834Returning Overseas Scholar Innovation Program CX2018062Returning Overseas Scholar Innovation Program CX2020045
6 · The paper itself

Abstract

Ferroptosis is a new form of regulated cell death, which is characterized by the iron-dependent accumulation of lethal lipid peroxides and involved in many critical diseases. Recent reports revealed that cellular energy metabolism activities such as glycolysis, pentose phosphate pathway (PPP), and tricarboxylic acid cycle are involved in the regulation of key ferroptosis markers such as reduced nicotinamide adenine dinucleotide phosphate (NADPH), glutathione (GSH), and reactive oxygen species (ROS), therefore imposing potential regulatory roles in ferroptosis. Remarkably, tumor cells can activate adaptive metabolic responses to inhibit ferroptosis for self-preservation such as the upregulation of glycolysis and PPP. Due to the rapid proliferation of tumor cells and the intensified metabolic rate, tumor energy metabolism has become a target for disrupting the redox homeostasis and induce ferroptosis. Based on these emerging insights, regulatory impact of those-tumor specific metabolic aberrations is systematically characterized, such as rewired glucose metabolism and metabolic compensation through glutamine utilization on ferroptosis and analyzed the underlying molecular mechanisms. Additionally, those ferroptosis-based therapeutic strategies are also discussed by exploiting those metabolic vulnerabilities, which may open up new avenues for tumor treatment in a clinical context.

Indexed as

Energy MetabolismFerroptosisHumansNeoplasmscellular energy metabolismferroptosisglucoseglutamine

Identifiers

PMID34632727
PMCPMC8596140
OpenAlexW3207848283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.